TDI-2760 is an Abeta aggregation inhibitor with an IC50 of 1.67 µM. TDI-2760 can inhibit the Abeta-fibrinogen interaction and Abeta aggregation, and also modulate the contact system activation induced by Abeta42. TDI-2760 can be used in research related to vascular abnormalities and Abeta aggregation in Alzheimers disease[1].
Molekulargewicht:
306.36
CAS Nummer:
[956128-08-8]
Formel:
C18H18N4O
Target-Kategorie:
Amyloid-beta
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten